O	0	7	Genetic	Genetic	JJ	B-NP
O	8	21	heterogeneity	heterogeneity	NN	I-NP
O	22	31	evidenced	evidence	VBN	B-VP
O	32	34	by	by	IN	B-PP
O	35	38	low	low	JJ	B-NP
O	39	48	incidence	incidence	NN	I-NP
O	49	51	of	of	IN	B-PP
O	52	55	KAL	KAL	NN	B-NP
O	55	56	-	-	HYPH	B-NP
O	56	57	1	1	CD	I-NP
O	58	62	gene	gene	NN	I-NP
O	63	72	mutations	mutation	NNS	I-NP
O	73	75	in	in	IN	B-PP
O	76	84	sporadic	sporadic	JJ	B-NP
O	85	90	cases	case	NNS	I-NP
O	91	93	of	of	IN	B-PP
O	94	106	gonadotropin	gonadotropin	NN	B-NP
O	106	107	-	-	HYPH	O
O	107	116	releasing	release	VBG	B-VP
O	117	124	hormone	hormone	NN	B-NP
O	125	135	deficiency	deficiency	NN	I-NP
O	135	136	.	.	.	O

O	137	145	Isolated	Isolate	VBN	B-NP
O	146	150	GnRH	GnRH	NN	I-NP
O	151	161	deficiency	deficiency	NN	I-NP
O	162	164	is	be	VBZ	B-VP
O	165	166	a	a	DT	B-NP
O	167	176	heritable	heritable	JJ	I-NP
O	177	186	condition	condition	NN	I-NP
O	187	200	characterized	characterize	VBN	B-VP
O	201	203	by	by	IN	B-PP
O	204	205	a	a	DT	B-NP
O	206	216	functional	functional	JJ	I-NP
O	217	224	deficit	deficit	NN	I-NP
O	225	227	in	in	IN	B-PP
O	228	232	GnRH	GnRH	NN	B-NP
O	233	242	secretion	secretion	NN	I-NP
O	242	243	.	.	.	O

O	244	252	Familial	Familial	JJ	B-NP
O	253	258	cases	case	NNS	I-NP
O	259	263	with	with	IN	B-PP
O	264	273	different	different	JJ	B-NP
O	274	279	modes	mode	NNS	I-NP
O	280	282	of	of	IN	B-PP
O	283	294	inheritance	inheritance	NN	B-NP
O	295	299	have	have	VBP	B-VP
O	300	304	been	be	VBN	I-VP
O	305	314	described	describe	VBN	I-VP
O	314	315	,	,	,	O
O	316	319	and	and	CC	O
O	320	323	the	the	DT	B-NP
O	324	328	gene	gene	NN	I-NP
O	329	340	responsible	responsible	JJ	B-ADJP
O	341	344	for	for	IN	B-PP
O	345	348	the	the	DT	B-NP
O	349	350	X	X	NN	I-NP
O	350	351	-	-	HYPH	B-VP
O	351	357	linked	link	VBN	I-VP
O	358	362	form	form	NN	B-NP
O	363	364	(	(	(	O
O	364	367	KAL	KAL	NN	B-NP
O	367	368	-	-	HYPH	B-NP
O	368	369	1	1	CD	I-NP
O	369	370	)	)	)	O
O	371	374	has	have	VBZ	B-VP
O	375	379	been	be	VBN	I-VP
O	380	390	identified	identify	VBN	I-VP
O	390	391	.	.	.	O

O	392	399	However	However	RB	B-ADVP
O	399	400	,	,	,	O
O	401	409	sporadic	sporadic	JJ	B-NP
O	410	415	cases	case	NNS	I-NP
O	416	420	with	with	IN	B-PP
O	421	423	no	no	DT	B-NP
O	424	434	documented	document	VBN	I-NP
O	435	441	family	family	NN	I-NP
O	442	449	history	history	NN	I-NP
O	450	452	of	of	IN	B-PP
O	453	457	GnRH	GnRH	NN	B-NP
O	458	468	deficiency	deficiency	NN	I-NP
O	469	476	account	account	NN	I-NP
O	477	480	for	for	IN	B-PP
O	481	484	the	the	DT	B-NP
O	485	493	majority	majority	NN	I-NP
O	494	496	of	of	IN	B-PP
O	497	500	the	the	DT	B-NP
O	501	509	affected	affect	VBN	I-NP
O	510	518	patients	patient	NNS	I-NP
O	518	519	.	.	.	O

O	520	523	For	For	IN	B-PP
O	524	528	this	this	DT	B-NP
O	529	535	reason	reason	NN	I-NP
O	535	536	,	,	,	O
O	537	539	we	we	PRP	B-NP
O	540	546	sought	seek	VBD	B-VP
O	547	549	to	to	TO	I-VP
O	550	559	determine	determine	VB	I-VP
O	560	563	the	the	DT	B-NP
O	564	573	frequency	frequency	NN	I-NP
O	574	578	with	with	IN	B-PP
O	579	584	which	which	WDT	B-NP
O	585	588	KAL	KAL	NN	B-NP
O	588	589	-	-	HYPH	I-NP
O	589	590	1	1	CD	I-NP
O	591	595	gene	gene	NN	I-NP
O	596	605	mutations	mutation	NNS	I-NP
O	606	611	occur	occur	VBP	B-VP
O	612	614	in	in	IN	B-PP
O	615	623	patients	patient	NNS	B-NP
O	624	628	with	with	IN	B-PP
O	629	637	sporadic	sporadic	JJ	B-NP
O	638	642	GnRH	GnRH	NN	I-NP
O	643	653	deficiency	deficiency	NN	I-NP
O	653	654	.	.	.	O

O	655	659	Only	Only	RB	B-NP
O	660	661	1	1	CD	I-NP
O	662	664	of	of	IN	B-PP
O	665	667	21	21	CD	B-NP
O	668	676	patients	patient	NNS	I-NP
O	677	681	with	with	IN	B-PP
O	682	690	sporadic	sporadic	JJ	B-NP
O	691	695	GnRH	GnRH	NN	I-NP
O	696	706	deficiency	deficiency	NN	I-NP
O	707	710	was	be	VBD	B-VP
O	711	716	found	find	VBN	I-VP
O	717	719	to	to	TO	I-VP
O	720	724	bear	bear	VB	I-VP
O	725	726	a	a	DT	B-NP
O	727	733	defect	defect	NN	I-NP
O	734	736	in	in	IN	B-PP
O	737	740	the	the	DT	B-NP
O	741	744	KAL	KAL	NN	I-NP
O	744	745	-	-	HYPH	B-NP
O	745	746	1	1	CD	I-NP
O	747	751	gene	gene	NN	I-NP
O	752	753	(	(	(	O
O	753	754	a	a	DT	B-NP
O	755	763	deletion	deletion	NN	I-NP
O	764	766	of	of	IN	B-PP
O	767	769	14	14	CD	B-NP
O	770	775	bases	base	NNS	I-NP
O	776	784	starting	start	VBG	B-VP
O	785	787	at	at	IN	B-PP
O	788	793	codon	codon	NN	B-NP
O	794	797	464	464	CD	I-NP
O	797	798	)	)	)	O
O	798	799	.	.	.	O

O	800	805	Three	Three	CD	B-NP
O	806	811	types	type	NNS	I-NP
O	812	814	of	of	IN	B-PP
O	815	826	polymorphic	polymorphic	JJ	B-NP
O	827	833	single	single	JJ	I-NP
O	834	838	base	base	NN	I-NP
O	839	852	substitutions	substitution	NNS	I-NP
O	853	857	with	with	IN	B-PP
O	858	860	no	no	DT	B-NP
O	861	869	apparent	apparent	JJ	I-NP
O	870	881	correlation	correlation	NN	I-NP
O	882	886	with	with	IN	B-PP
O	887	891	GnRH	GnRH	NN	B-NP
O	892	902	deficiency	deficiency	NN	I-NP
O	903	907	were	be	VBD	B-VP
O	908	912	also	also	RB	I-VP
O	913	921	detected	detect	VBN	I-VP
O	922	924	in	in	IN	B-PP
O	925	932	several	several	JJ	B-NP
O	933	941	patients	patient	NNS	I-NP
O	941	942	.	.	.	O

O	943	945	In	In	IN	B-PP
O	946	950	each	each	DT	B-NP
O	951	953	of	of	IN	B-PP
O	954	955	3	3	CD	B-NP
O	956	965	different	different	JJ	I-NP
O	966	974	patients	patient	NNS	I-NP
O	975	979	with	with	IN	B-PP
O	980	982	an	an	DT	B-NP
O	983	984	X	X	NN	I-NP
O	984	985	-	-	HYPH	B-VP
O	985	991	linked	link	VBN	B-NP
O	992	996	mode	mode	NN	I-NP
O	997	999	of	of	IN	B-PP
O	1000	1011	inheritance	inheritance	NN	B-NP
O	1011	1012	,	,	,	O
O	1013	1014	3	3	CD	B-NP
O	1015	1022	genetic	genetic	JJ	I-NP
O	1023	1030	defects	defect	NNS	I-NP
O	1030	1031	,	,	,	O
O	1032	1033	2	2	CD	B-NP
O	1034	1039	point	point	NN	I-NP
O	1040	1049	mutations	mutation	NNS	I-NP
O	1050	1053	and	and	CC	O
O	1054	1055	a	a	DT	B-NP
O	1056	1061	small	small	JJ	I-NP
O	1062	1072	intragenic	intragenic	JJ	I-NP
O	1073	1081	deletion	deletion	NN	I-NP
O	1081	1082	,	,	,	O
O	1083	1087	were	be	VBD	B-VP
O	1088	1096	detected	detect	VBN	I-VP
O	1096	1097	.	.	.	O

O	1098	1103	These	These	DT	B-NP
O	1104	1111	defects	defect	NNS	I-NP
O	1112	1119	consist	consist	VBP	B-VP
O	1120	1122	of	of	IN	B-PP
O	1123	1124	a	a	DT	B-NP
O	1125	1131	single	single	JJ	I-NP
O	1132	1136	base	base	NN	I-NP
O	1137	1145	mutation	mutation	NN	I-NP
O	1146	1157	introducing	introduce	VBG	B-VP
O	1158	1159	a	a	DT	B-NP
O	1160	1164	stop	stop	NN	I-NP
O	1165	1170	codon	codon	NN	I-NP
O	1171	1173	at	at	IN	B-PP
O	1174	1182	position	position	NN	B-NP
O	1183	1186	328	328	CD	I-NP
O	1186	1187	,	,	,	O
O	1188	1189	a	a	DT	B-NP
O	1190	1196	single	single	JJ	I-NP
O	1197	1201	base	base	NN	I-NP
O	1202	1210	mutation	mutation	NN	I-NP
O	1211	1220	resulting	result	VBG	B-VP
O	1221	1223	in	in	IN	B-PP
O	1224	1225	a	a	DT	B-NP
O	1226	1239	phenylalanine	phenylalanine	NN	I-NP
O	1240	1242	to	to	TO	B-PP
O	1243	1250	leucine	leucine	NN	B-NP
O	1251	1263	substitution	substitution	NN	I-NP
O	1264	1266	at	at	IN	B-PP
O	1267	1275	position	position	NN	B-NP
O	1276	1279	517	517	CD	I-NP
O	1279	1280	,	,	,	O
O	1281	1284	and	and	CC	O
O	1285	1286	a	a	DT	B-NP
O	1287	1288	9	9	CD	I-NP
O	1288	1289	-	-	HYPH	I-NP
O	1289	1293	base	base	NN	I-NP
O	1294	1302	deletion	deletion	NN	I-NP
O	1303	1305	at	at	IN	B-PP
O	1306	1309	the	the	DT	B-NP
O	1310	1311	3	3	CD	I-NP
O	1311	1312	'	'	SYM	I-NP
O	1312	1313	-	-	HYPH	I-NP
O	1313	1317	exon	exon	NN	I-NP
O	1317	1318	-	-	HYPH	I-NP
O	1318	1324	intron	intron	NN	I-NP
O	1325	1331	splice	splice	NN	I-NP
O	1332	1336	site	site	NN	I-NP
O	1337	1339	of	of	IN	B-PP
O	1340	1344	exon	exon	NN	B-NP
O	1345	1346	8	8	CD	I-NP
O	1346	1347	,	,	,	O
O	1348	1360	respectively	respectively	RB	B-ADVP
O	1360	1361	.	.	.	O

O	1362	1365	All	All	DT	B-NP
O	1366	1376	identified	identify	VBN	I-NP
O	1377	1384	genetic	genetic	JJ	I-NP
O	1385	1392	defects	defect	NNS	I-NP
O	1393	1398	occur	occur	VBP	B-VP
O	1399	1405	within	within	IN	B-PP
O	1406	1409	the	the	DT	B-NP
O	1410	1421	fibronectin	fibronectin	NN	I-NP
O	1422	1426	type	type	NN	I-NP
O	1427	1430	III	III	CD	B-NP
O	1431	1438	repeats	repeat	NNS	I-NP
O	1439	1441	of	of	IN	B-PP
O	1442	1445	the	the	DT	B-NP
O	1446	1455	predicted	predict	VBN	I-NP
O	1456	1463	protein	protein	NN	I-NP
O	1464	1471	encoded	encode	VBN	B-VP
O	1472	1474	by	by	IN	B-PP
O	1475	1478	the	the	DT	B-NP
O	1479	1482	KAL	KAL	NN	I-NP
O	1482	1483	-	-	HYPH	B-NP
O	1483	1484	1	1	CD	I-NP
O	1485	1489	gene	gene	NN	I-NP
O	1489	1490	.	.	.	O

O	1491	1493	In	In	IN	B-PP
O	1494	1504	conclusion	conclusion	NN	B-NP
O	1504	1505	,	,	,	O
O	1506	1509	our	our	PRP$	B-NP
O	1510	1515	study	study	NN	I-NP
O	1516	1525	indicates	indicate	VBZ	B-VP
O	1526	1530	that	that	IN	B-SBAR
O	1531	1534	the	the	DT	B-NP
O	1535	1544	incidence	incidence	NN	I-NP
O	1545	1547	of	of	IN	B-PP
O	1548	1555	genetic	genetic	JJ	B-NP
O	1556	1563	defects	defect	NNS	I-NP
O	1564	1570	within	within	IN	B-PP
O	1571	1574	the	the	DT	B-NP
O	1575	1581	coding	cod	VBG	I-NP
O	1582	1588	region	region	NN	I-NP
O	1589	1591	of	of	IN	B-PP
O	1592	1595	the	the	DT	B-NP
O	1596	1599	KAL	KAL	NN	I-NP
O	1599	1600	-	-	HYPH	B-NP
O	1600	1601	1	1	CD	I-NP
O	1602	1606	gene	gene	NN	I-NP
O	1607	1609	in	in	IN	B-PP
O	1610	1618	patients	patient	NNS	B-NP
O	1619	1623	with	with	IN	B-PP
O	1624	1632	sporadic	sporadic	JJ	B-NP
O	1633	1637	GnRH	GnRH	NN	I-NP
O	1638	1648	deficiency	deficiency	NN	I-NP
O	1649	1651	is	be	VBZ	B-VP
O	1652	1655	low	low	JJ	B-ADJP
O	1656	1657	(	(	(	O
O	1657	1658	5	5	CD	B-NP
O	1658	1659	-	-	HYPH	I-NP
O	1659	1660	8	8	CD	I-NP
O	1660	1661	%	%	NN	I-NP
O	1661	1662	)	)	)	O
O	1662	1663	,	,	,	O
O	1664	1668	thus	thus	RB	B-ADVP
O	1669	1679	supporting	support	VBG	B-VP
O	1680	1683	the	the	DT	B-NP
O	1684	1688	idea	idea	NN	I-NP
O	1689	1693	that	that	IN	B-SBAR
O	1694	1697	the	the	DT	B-NP
O	1698	1699	X	X	NN	I-NP
O	1699	1700	-	-	HYPH	B-VP
O	1700	1706	linked	link	VBN	B-NP
O	1707	1711	form	form	NN	I-NP
O	1712	1714	of	of	IN	B-PP
O	1715	1726	inheritance	inheritance	NN	B-NP
O	1727	1737	represents	represent	VBZ	B-VP
O	1738	1741	the	the	DT	B-NP
O	1742	1747	least	least	JJS	I-NP
O	1748	1754	common	common	JJ	I-NP
O	1755	1759	form	form	NN	I-NP
O	1760	1762	of	of	IN	B-PP
O	1763	1766	the	the	DT	B-NP
O	1767	1774	disease	disease	NN	I-NP
O	1774	1775	.	.	.	O

